Christopher B. Ehrlich, Director at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 941,177 shares at $8.50 ($8.0M) on 2009-04-07, disclosed to the SEC on 2009-04-08.
Open-market purchase of $8.0M BMTI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| EFTR | BUY | 2022-02-22 | $13K | — | Filing → |
| EFTR | BUY | 2022-02-10 | $10K | — | Filing → |
| EFTR | BUY | 2022-02-07 | $31K | — | Filing → |